These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
The Association of Medical Research Charities (AMRC) is calling on the Government to match-fund research in the sector over the next three years.Read more
A recent survey by the Association of Medical Research Charities (AMRC) has found that members – including Muscular Dystrophy UK – will experience an average loss of 38 percen
Roche, the pharmaceutical company behind the SMA treatment Risdiplam, has extended its compassionate use programme to potentially include patients who cannot receive Spinraza becau
Joint letter to NICE regarding the suspension of the appraisal process for ridisplam
Muscular Dystrophy UK regrets to announce that, due to the financial effect Covid-19 is having on our ability to generate income, we are cancelling the current Grant Round in 2020.
For this year’s British Science Week, the theme of which is “Our Diverse Planet”, we’d like to tell you about some exciting research we’ve funded.
Updated guidance on the medicines that should be avoided or used with caution in people with primary mitochondrial disease from the IMP
Research is being carried out looking at the impact of Duchenne on family carers.
The results from the MDUK-funded research project gives insight into the drugs, ezutromid
The ENMC is an international organisation that supports research for neuromuscular conditions and strives to facilitate communication among scientists and clinicians.
Updates on Roche's SMA drug, risdiplam